114 related articles for article (PubMed ID: 2735495)
1. [Oral dyskinesia in rats after a single administration of haloperidol combined with GABA-linoleamide. A model of dyskinesia in man].
Vamvakides A
Agressologie; 1989 Feb; 30(2):89-91. PubMed ID: 2735495
[TBL] [Abstract][Full Text] [Related]
2. [Vacuous chewing after haloperidol and GABA-linoleamide administration in the rat].
Vamvakidès A
Agressologie; 1986 Nov; 27(10):819-21. PubMed ID: 3812899
[No Abstract] [Full Text] [Related]
3. [Effect of glycine-steatamide or glutamic acid palmitamide on oral dyskinesia, obtained by a single administration of haloperidol combined with GABA-linoleamide in rats].
Vamvakidès A
Ann Pharm Fr; 1988; 46(4):261-6. PubMed ID: 3074729
[No Abstract] [Full Text] [Related]
4. A model for oral dyskinesia in rats.
Gunne LM; Growdon JH
J Clin Psychopharmacol; 1982 Oct; 2(5):308-11. PubMed ID: 6290544
[TBL] [Abstract][Full Text] [Related]
5. [Effect of GABA-linoleamide and glycine-linoleamide on catalepsy in the rat after chronic administration of reserpine].
Vamvakidès A
Agressologie; 1986 Nov; 27(10):835-7. PubMed ID: 3028195
[No Abstract] [Full Text] [Related]
6. Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats.
Kaneda H; Shirakawa O; Dale J; Goodman L; Bachus SE; Tamminga CA
Eur J Pharmacol; 1992 Feb; 212(1):43-9. PubMed ID: 1555638
[TBL] [Abstract][Full Text] [Related]
7. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
[TBL] [Abstract][Full Text] [Related]
8. [Catalepsy in the rat after haloperidol and some new GABA-ergic agents].
Vamvakidès A
Agressologie; 1984 Oct; 25(9):1011-6. PubMed ID: 6542324
[No Abstract] [Full Text] [Related]
9. Clozapine in tardive dyskinesia: observations from human and animal model studies.
Tamminga CA; Thaker GK; Moran M; Kakigi T; Gao XM
J Clin Psychiatry; 1994 Sep; 55 Suppl B():102-6. PubMed ID: 7961550
[TBL] [Abstract][Full Text] [Related]
10. [Effect of GABA-linoleamide and glycine linoleamide on pentamethylenetetrazole convulsions].
Vamvakidès A
J Pharmacol; 1986; 17(3):323-7. PubMed ID: 3025524
[TBL] [Abstract][Full Text] [Related]
11. [2 new GABA-ergics (GABA-linoleamide and GABA-steatamide). On 2 experimental models of depression].
Vamvakidès A
Agressologie; 1985 Jun; 26(7):597-9. PubMed ID: 4041141
[No Abstract] [Full Text] [Related]
12. Protective effect of hesperetin against haloperidol-induced orofacial dyskinesia and catalepsy in rats.
Dhingra D; Goswami S; Gahalain N
Nutr Neurosci; 2018 Nov; 21(9):667-675. PubMed ID: 28641484
[TBL] [Abstract][Full Text] [Related]
13. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
14. Expression of glutamic acid decarboxylase mRNA in striatum and pallidum in an animal model of tardive dyskinesia.
Delfs JM; Ellison GD; Mercugliano M; Chesselet MF
Exp Neurol; 1995 Jun; 133(2):175-88. PubMed ID: 7544289
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of adenosine reuptake inhibitors in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacology; 2007; 79(3):171-83. PubMed ID: 17377417
[TBL] [Abstract][Full Text] [Related]
16. Tiagabine inhibits haloperidol-induced oral dyskinesias in rats.
Gao XM; Kakigi T; Friedman MB; Tamminga CA
J Neural Transm Gen Sect; 1994; 95(1):63-9. PubMed ID: 7857587
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum.
Roberts RC; Gaither LA; Gao XM; Kashyap SM; Tamminga CA
Synapse; 1995 Jul; 20(3):234-43. PubMed ID: 7570355
[TBL] [Abstract][Full Text] [Related]
18. Experimental tardive dyskinesia.
Gunne LM; Häggström JE
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):48-50. PubMed ID: 2858481
[TBL] [Abstract][Full Text] [Related]
19. Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.
Gunne LM; Häggström JE
Psychopharmacology (Berl); 1983; 81(3):191-4. PubMed ID: 6139837
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
